Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AVAN
FechaHoraFuenteTítuloSímboloCompañía
29/09/200816:02Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200810:43Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200807:00Business WireAVANT Immunotherapeutics Announces Name Change to Celldex TherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
19/09/200809:28Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/09/200815:00Business WireAVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23NASDAQ:AVANAvant Immunotherapeutics (MM)
13/08/200815:53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVANAvant Immunotherapeutics (MM)
08/08/200815:16Business WireAVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200807:46Business WireCORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200807:00Business WireAVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
04/08/200812:56Business WireAVANT to Report Second Quarter 2008 Financial Results on August 6, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
26/06/200815:47Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/06/200810:13Edgar (US Regulatory)Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AVANAvant Immunotherapeutics (MM)
11/06/200807:00Business WireAVANT Announces Vaccine Adjuvant Licenses with 3MNASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200809:00Business WireAVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200806:00Business WireNIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
03/06/200807:30MarketwiredMarket Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in DeNASDAQ:AVANAvant Immunotherapeutics (MM)
02/06/200813:32MarketwiredNew Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYONDNASDAQ:AVANAvant Immunotherapeutics (MM)
23/05/200815:04Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Current report filing (8-K/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
22/05/200806:00PR Newswire (US)AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual MeetingNASDAQ:AVANAvant Immunotherapeutics (MM)
21/05/200806:00PR Newswire (US)AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to PfizerNASDAQ:AVAN
19/05/200816:27Edgar (US Regulatory)Avant Immunotherapeutics Inc - Quarterly Report (10-Q)NASDAQ:AVANAvant Immunotherapeutics (MM)
19/05/200816:33Business WireAVANT Reports First Quarter 2008 Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
16/05/200817:16Business WireAVANT Announces Temporary Postponement of Conference CallNASDAQ:AVANAvant Immunotherapeutics (MM)
14/05/200815:00Business WireAVANT to Report First Quarter 2008 Financial Results on May 19, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
14/05/200807:00Business WireDr. Una Ryan Departs AVANT ImmunotherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
09/05/200809:53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)NASDAQ:AVANAvant Immunotherapeutics (MM)
16/04/200815:41Business WireAVANT to Host Conference Call Today, April 16, 2008, at 5:00 PM to Discuss CDX-110 Partnership with PfizerNASDAQ:AVANAvant Immunotherapeutics (MM)
16/04/200815:37Business WirePfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain CancerNASDAQ:AVANAvant Immunotherapeutics (MM)
15/04/200815:05Business WireSignificant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for TreatmentNASDAQ:AVANAvant Immunotherapeutics (MM)
04/04/200807:41Business WireFDA Approves ROTARIX(R) Rotavirus VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:AVAN

Su Consulta Reciente

Delayed Upgrade Clock